X4 Pharmaceuticals Inc (XFOR)
1.15
+0.07
(+6.48%)
USD |
NASDAQ |
May 03, 16:00
1.14
-0.01
(-0.87%)
After-Hours: 20:00
X4 Pharmaceuticals Price to Book Value: 3.780 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.780 |
| May 02, 2024 | 3.549 |
| May 01, 2024 | 3.632 |
| April 30, 2024 | 3.681 |
| April 29, 2024 | 3.582 |
| April 26, 2024 | 3.829 |
| April 25, 2024 | 3.714 |
| April 24, 2024 | 4.240 |
| April 23, 2024 | 4.042 |
| April 22, 2024 | 4.470 |
| April 19, 2024 | 4.141 |
| April 18, 2024 | 3.944 |
| April 17, 2024 | 3.927 |
| April 16, 2024 | 4.338 |
| April 15, 2024 | 4.108 |
| April 12, 2024 | 4.404 |
| April 11, 2024 | 4.059 |
| April 10, 2024 | 4.010 |
| April 09, 2024 | 4.174 |
| April 08, 2024 | 4.240 |
| April 05, 2024 | 4.502 |
| April 04, 2024 | 4.831 |
| April 03, 2024 | 4.831 |
| April 02, 2024 | 4.535 |
| April 01, 2024 | 4.634 |
| Date | Value |
|---|---|
| March 28, 2024 | 4.568 |
| March 27, 2024 | 4.634 |
| March 26, 2024 | 4.766 |
| March 25, 2024 | 4.798 |
| March 22, 2024 | 4.798 |
| March 21, 2024 | 4.305 |
| March 20, 2024 | 3.352 |
| March 19, 2024 | 3.191 |
| March 18, 2024 | 3.034 |
| March 15, 2024 | 3.039 |
| March 14, 2024 | 2.746 |
| March 13, 2024 | 2.758 |
| March 12, 2024 | 2.835 |
| March 11, 2024 | 2.991 |
| March 08, 2024 | 2.884 |
| March 07, 2024 | 3.004 |
| March 06, 2024 | 3.157 |
| March 05, 2024 | 3.126 |
| March 04, 2024 | 3.190 |
| March 01, 2024 | 3.309 |
| February 29, 2024 | 3.180 |
| February 28, 2024 | 3.047 |
| February 27, 2024 | 3.262 |
| February 26, 2024 | 3.117 |
| February 23, 2024 | 3.072 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5456
Minimum
Jun 29 2022
9.142
Maximum
May 14 2019
2.129
Average
1.768
Median
Dec 12 2022
Price to Book Value Benchmarks
| Phio Pharmaceuticals Corp | 0.4869 |
| Ocular Therapeutix Inc | 10.06 |
| Alpine Immune Sciences Inc | 12.91 |
| Scholar Rock Holding Corp | 5.307 |
| Pyxis Oncology Inc | 2.026 |
Price to Book Value Related Metrics
| Price | 1.15 |
| Earnings Yield | -51.30% |
| Market Cap | 193.13M |